Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1996. Start Trial.
Date Value
November 12, 2026 5.443
November 11, 2026 5.494
November 10, 2026 5.485
November 09, 2026 5.427
November 06, 2026 5.427
November 05, 2026 5.514
November 04, 2026 5.606
November 03, 2026 5.390
November 02, 2026 5.504
October 30, 2026 5.457
October 29, 2026 5.362
October 28, 2026 5.290
October 27, 2026 5.376
October 26, 2026 5.381
October 23, 2026 5.369
October 22, 2026 5.502
October 21, 2026 5.338
October 20, 2026 5.387
October 19, 2026 5.138
October 16, 2026 5.218
October 15, 2026 5.290
October 14, 2026 5.177
October 13, 2026 4.949
October 12, 2026 5.029
October 09, 2026 5.163
Date Value
October 08, 2026 5.203
October 07, 2026 5.214
October 06, 2026 5.204
October 05, 2026 5.136
October 02, 2026 5.341
October 01, 2026 5.368
September 30, 2026 5.450
September 29, 2026 5.754
September 28, 2026 5.847
September 25, 2026 5.754
September 24, 2026 5.630
September 23, 2026 5.597
September 22, 2026 5.698
September 21, 2026 5.732
September 18, 2026 5.772
September 17, 2026 5.752
September 16, 2026 5.822
September 15, 2026 5.834
September 14, 2026 5.868
September 11, 2026 5.825
September 10, 2026 5.835
September 09, 2026 5.896
September 08, 2026 5.922
September 04, 2026 6.116
September 03, 2026 6.233

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Johnson & Johnson 8.424
Eli Lilly & Co. 33.25
Merck & Co., Inc. 8.011
Pfizer Inc. 1.843
AstraZeneca PLC 12.12

Price to Book Value Related Metrics